Do platform-specific factors explain microRNA profiling disparities?

Clinical Chemistry

Volumn 58, Issue 2, 2012, Pages 472-474

  Watson, Andria K ^a   Witwer, Kenneth W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ANALYTIC METHOD; BODY FLUID; CALIBRATION; CENTRAL NERVOUS SYSTEM DISEASE; CORRELATION ANALYSIS; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMAN; LETTER; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; RNA ANALYSIS;

BODY FLUIDS; FEMALE; HUMANS; MICRORNAS; PREGNANCY;

EID: 84856391671     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.175281     Document Type: Letter

References (5)

1. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010;56:1733-41.
2. Witwer KW, Sarbanes SL, Liu J, Clements JE. A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease. AIDS 2011;25:2057-67.
3. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011;108: 5003-8.
4. Lee LW, Zhang S, Etheridge A, Ma L, Martin D, Galas D, et al. Complexity of the microRNA repertoire revealed by next-generation sequencing. RNA 2010;16:2170-80.
5. Zubakov D, Boersma AW, Choi Y, van Kuijk PF, Wiemer EA, Kayser M. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int J Legal Med 2010;124:217-26.